Sunitinib AqVida hard capsules*

Sunitinib AqVida hard capsules*
Product Description

12.5 mg, 25 mg, 37.5 mg, 50 mg CapsuleIndications: Treatment of mRCC, GIST * Products protected by valid patents are not offered in countries where the sale constitutes a patent infringement.

AqVida GmbH

  • Country/Region:
    Germany
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    50 - 99
Company types
Distributor/Import Export
Manufacturer/Innovator

AqVida GmbH

  • Country/Region:
    Germany
  • On CPHI since:
    2015
  • Certificates:
    2
  • Employees:
    50 - 99
Company types
Distributor/Import Export
Manufacturer/Innovator

More Products from AqVida GmbH (11)

AqVida GmbH resources (1)